<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">Furthermore, respiratory infections may account for only a small proportion of the morbidity and mortality caused by influenza. Acute respiratory infections, including those caused by influenza viruses, can exacerbate asthma and COPD, yet in few such episodes is testing for influenza undertaken [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR3">3</xref>, 
 <xref ref-type="bibr" rid="CR5">5</xref>]. Acute influenza can also lead to decompensation of patients with congestive heart failure or diabetes mellitus and to an increased risk of myocardial infarction and cerebrovascular accident, but such patients are rarely tested for influenza [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR4">4</xref>, 
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR7">7</xref>]. Similarly, influenza virus can cause acute otitis media and is associated with increased risk of Guillain-Bar≈ïe Syndrome [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR14">14</xref>]. Collectively, these non-specific adverse health outcomes may produce as high a disease burden as ILI and SARI. In addition, delayed effects of infections will be overlooked by standard approaches to assessing influenza-related burden of illness.
</p>
